Page last updated: 2024-11-06

1,1'-diethyl-2,2'-cyanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pseudoisocyanine: metachromatic quinoline tissue stain; may polymerize to yield different colors; also used in fluorescence cytochemistry may bind to DNA; minor descriptor (79-86); on-line & INDEX MEDICUS search QUINOLINES (79-86); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5464573
MeSH IDM0263190

Synonyms (12)

Synonym
pseudoisocyanine
nsc-97374
1,1'-diethyl-2,2'-cyanine
1-ethyl-2-((1-ethyl-2(1h)-quinolylidene)methyl)quinolinium
sq2a744rss ,
quinolinium, 1-ethyl-2-((1-ethyl-2(1h)-quinolinylidene)methyl)-
pseudocyanine
unii-sq2a744rss
diethylpseudoisocyanine
1-ethyl-2-[(1-ethyl-2(1h)-quinolinylidene)methyl]quinolinium
1-ethyl-2-((1-ethyl-2(1h)-quinolinylidene)methyl)quinolinium
1,1'-diethyl-2,2'-quinocyanine

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The organic cation transporter-3 (OCT3) is a glucocorticoid-sensitive uptake mechanism that has been shown to regulate the bioavailability of monoamines in brain regions that are implicated in the pathophysiology of depression."( Modulation of OCT3 expression by stress, and antidepressant-like activity of decynium-22 in an animal model of depression.
Devine, DP; Marcinkiewcz, CA, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
1,1'-diethyl-2,2'-cyanine
quinolinesA class of aromatic heterocyclic compounds each of which contains a benzene ring ortho fused to carbons 2 and 3 of a pyridine ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (9.62)18.7374
1990's4 (7.69)18.2507
2000's17 (32.69)29.6817
2010's20 (38.46)24.3611
2020's6 (11.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other58 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]